Integrating Network Pharmacology and Bioinformatics to Explore the Effects of Dangshen (Codonopsis pilosula) Against Hepatocellular Carcinoma: Validation Based on the Active Compound Luteolin

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135(5):584–590. doi:10.1097/CM9.0000000000002108
   PubMed Web of Science ®Google Scholar
• Cao M, Li H, Sun D, Chen W. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun. 2020;40(5):205–210. doi:10.1002/cac2.12025
   PubMed Web of Science ®Google Scholar
• Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi:10.1056/NEJMra1713263
   PubMed Web of Science ®Google Scholar
• Pinero F, Dirchwolf M, Pessoa MG. Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment. Cells. 2020;9(6):1370. doi:10.3390/cells9061370
   PubMed Web of Science ®Google Scholar
• Qiu Z, Li H, Zhang Z, et al. A pharmacogenomic landscape in human liver cancers. Cancer Cell. 2019;36(2):179–193 e11. doi:10.1016/j.ccell.2019.07.001
   PubMed Web of Science ®Google Scholar
• Liu C, Yang S, Wang K, et al. Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma. Biomed Pharmacother. 2019;120:109543. doi:10.1016/j.biopha.2019.109543
   PubMed Web of Science ®Google Scholar
• Dong S, Zhuang X, Yangyang L, et al. Efficacy and safety of acupuncture combined with Chinese herbal medicine in the treatment of primary liver cancer: a protocol for systematic review and meta-analysis. Medicine. 2021;100(40):e27497. doi:10.1097/MD.0000000000027497
   PubMed Web of Science ®Google Scholar
• Tsai F-J, Liu X, Chen C-J, et al. Chinese herbal medicine therapy and the risk of overall mortality for patients with liver cancer who underwent surgical resection in Taiwan. Complement Ther Med. 2019;47:102213. doi:10.1016/j.ctim.2019.102213
   PubMed Web of Science ®Google Scholar
• Liao Y-H, Lin C-C, Lai H-C, Chiang J-H, Lin J-G, Li T-C. Adjunctive traditional Chinese medicine therapy improves survival of liver cancer patients. Liver Int. 2015;35(12):2595–2602. doi:10.1111/liv.12847
   PubMed Web of Science ®Google Scholar
• Tang S, Liu W, Zhao Q, et al. Combination of polysaccharides from Astragalus membranaceus and Codonopsis pilosula ameliorated mice colitis and underlying mechanisms. J Ethnopharmacol. 2021;264:113280. doi:10.1016/j.jep.2020.113280
   PubMed Web of Science ®Google Scholar
• Hu Y, Sun J, Wang T, et al. Compound Danshen Dripping Pill inhibits high altitude-induced hypoxic damage by suppressing oxidative stress and inflammatory responses. Pharm Biol. 2021;59(1):1585–1593. doi:10.1080/13880209.2021.1998139
   PubMed Web of Science ®Google Scholar
• Zou Y-F, Zhang -Y-Y, Paulsen BS, et al. New pectic polysaccharides from Codonopsis pilosula and Codonopsis tangshen: structural characterization and cellular antioxidant activities. J Sci Food Agric. 2021;101(14):6043–6052. doi:10.1002/jsfa.11261
   PubMed Web of Science ®Google Scholar
• Zhang P, Hu L, Bai R, et al. Structural characterization of a pectic polysaccharide from Codonopsis pilosula and its immunomodulatory activities in vivo and in vitro. Int J Biol Macromol. 2017;104(Pt A):1359–1369. doi:10.1016/j.ijbiomac.2017.06.023
   PubMedGoogle Scholar
• Bai R-B, Zhang Y-J, Fan J-M, et al. Immune-enhancement effects of oligosaccharides from Codonopsis pilosula on cyclophosphamide induced immunosuppression in mice. Food Funct. 2020;11(4):3306–3315. doi:10.1039/c9fo02969a
   PubMed Web of Science ®Google Scholar
• Huo J, Qin F, Cai X, et al. Chinese medicine formula “Weikang Keli” induces autophagic cell death on human gastric cancer cell line SGC-7901. Phytomedicine. 2013;20(2):159–165. doi:10.1016/j.phymed.2012.10.001
   PubMed Web of Science ®Google Scholar
• Liu H, Amakye WK, Ren J. Codonopsis pilosula polysaccharide in synergy with dacarbazine inhibits mouse melanoma by repolarizing M2-like tumor-associated macrophages into M1-like tumor-associated macrophages. Biomed Pharmacother. 2021;142:112016. doi:10.1016/j.biopha.2021.112016
   PubMed Web of Science ®Google Scholar
• Liu Y, Zou X, Sun G, Bao Y. Codonopsis lanceolata polysaccharide CLPS inhibits melanoma metastasis via regulating integrin signaling. Int J Biol Macromol. 2017;103:435–440. doi:10.1016/j.ijbiomac.2017.05.093
   PubMed Web of Science ®Google Scholar
• Gong Y-B, Fu S-J, Wei Z-R, Liu J-G, Rehman G. Predictive study of the active ingredients and potential targets of Codonopsis pilosula for the treatment of osteosarcoma via network pharmacology. Evid Based Complement Alternat Med. 2021;2021:1480925. doi:10.1155/2021/1480925
   PubMed Web of Science ®Google Scholar
• Jiang N, Li H, Sun Y, et al. Network pharmacology and pharmacological evaluation reveals the mechanism of the sanguisorba officinalis in suppressing hepatocellular carcinoma. Front Pharmacol. 2021;12:618522. doi:10.3389/fphar.2021.618522
   PubMed Web of Science ®Google Scholar
• Zhang S, Mo Z, Zhang S, Li X. A network pharmacology approach to reveal the underlying mechanisms of Artemisia annua on the treatment of hepatocellular carcinoma. Evid Based Complement Alternat Med. 2021;2021:8947304. doi:10.1155/2021/8947304
   PubMed Web of Science ®Google Scholar
• Yang A-L, Wu Q, Hu Z-D, et al. A network pharmacology approach to investigate the anticancer mechanism of cinobufagin against hepatocellular carcinoma via downregulation of EGFR-CDK2 signaling. Toxicol Appl Pharmacol. 2021;431:115739. doi:10.1016/j.taap.2021.115739
   PubMed Web of Science ®Google Scholar
• Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6(1):13. doi:10.1186/1758-2946-6-13
   PubMed Web of Science ®Google Scholar
• Ding R, Qu Y, Wu CH, Vijay-Shanker K. Automatic gene annotation using GO terms from cellular component domain. BMC Med Inform Decis Mak. 2018;18(Suppl S5):119. doi:10.1186/s12911-018-0694-7
   PubMedGoogle Scholar
• Deng Y, Ye X, Chen Y, et al. Chemical characteristics of Platycodon grandiflorum and its mechanism in lung cancer treatment. Front Pharmacol. 2021;11:609825. doi:10.3389/fphar.2020.609825
   PubMed Web of Science ®Google Scholar
• Dong Y, Hao L, Fang K, et al. A network pharmacology perspective for deciphering potential mechanisms of action of Solanum nigrum L. in bladder cancer. BMC Complement Med Ther. 2021;21(1):45. doi:10.1186/s12906-021-03215-3
   PubMedGoogle Scholar
• Jeon Y, Yoo JE, Rhee H, et al. YAP inactivation in estrogen receptor alpha-positive hepatocellular carcinoma with less aggressive behavior. Exp Mol Med. 2021;53(6):1055–1067. doi:10.1038/s12276-021-00639-2
   PubMed Web of Science ®Google Scholar
• Xiao H, Wang B, Xiong HX, et al. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis. J Cell Physiol. 2021;236(4):2572–2591. doi:10.1002/jcp.30015
   PubMed Web of Science ®Google Scholar
• Chen YQ, Zheng L, Zhou J, et al. Evaluation of plasma LC3B(+)extracellular vesicles as a potential novel diagnostic marker for hepatocellular carcinoma. Int Immunopharmacol. 2022;108:108760. doi:10.1016/j.intimp.2022.108760
   PubMed Web of Science ®Google Scholar
• Chen W, Li G, Peng J, Dai W, Su Q, He Y. Transcriptomic analysis reveals that heat shock protein 90 alpha is a potential diagnostic and prognostic biomarker for cancer. Eur J Cancer Prev. 2020;29(4):357–364. doi:10.1097/CEJ.0000000000000549
   PubMed Web of Science ®Google Scholar
• Yu J, Ma S, Tian S, et al. Systematic construction and validation of a prognostic model for hepatocellular carcinoma based on immune-related genes. Front Cell Dev Biol. 2021;9:700553. doi:10.3389/fcell.2021.700553
   PubMed Web of Science ®Google Scholar
• Hu X, Pan H, Zhou S, et al. HS1BP3, transcriptionally regulated by ESR1, promotes hepatocellular carcinoma progression. Biochem Biophys Res Commun. 2022;623:111–119. doi:10.1016/j.bbrc.2022.07.047
   PubMed Web of Science ®Google Scholar
• Wu H, Yao S, Zhang S, et al. Elevated expression of Erbin destabilizes ERalpha protein and promotes tumorigenesis in hepatocellular carcinoma. J Hepatol. 2017;66(6):1193–1204. doi:10.1016/j.jhep.2017.01.030
   PubMed Web of Science ®Google Scholar
• Imran M, Rauf A, Abu-Izneid T, et al. Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacother. 2019;112:108612. doi:10.1016/j.biopha.2019.108612
   PubMed Web of Science ®Google Scholar
• Im E, Yeo C, Lee EO. Luteolin induces caspase-dependent apoptosis via inhibiting the AKT/osteopontin pathway in human hepatocellular carcinoma SK-Hep-1 cells. Life Sci. 2018;209:259–266. doi:10.1016/j.lfs.2018.08.025
   PubMed Web of Science ®Google Scholar
• Elsayed MMA, Okda TM, Atwa GMK, Omran GA, Abd Elbaky AE, Ramadan AEH. Design and optimization of orally administered luteolin nanoethosomes to enhance its anti-tumor activity against hepatocellular carcinoma. Pharmaceutics. 2021;13(5):648. doi:10.3390/pharmaceutics13050648
   PubMed Web of Science ®Google Scholar
• Cai S, Bai Y, Wang H, et al. Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin. J Exp Clin Cancer Res. 2020;39(1):135. doi:10.1186/s13046-020-01634-7
   PubMed Web of Science ®Google Scholar
• Lee HJ, Wang CJ, Kuo HC, Chou FP, Jean LF, Tseng TH. Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK. Toxicol Appl Pharmacol. 2005;203(2):124–131. doi:10.1016/j.taap.2004.08.004
   PubMed Web of Science ®Google Scholar
• Yee SB, Choi HJ, Chung SW, et al. Growth inhibition of luteolin on HepG2 cells is induced via p53 and Fas/Fas-ligand besides the TGF-beta pathway. Int J Oncol. 2015;47(2):747–754. doi:10.3892/ijo.2015.3053
   PubMed Web of Science ®Google Scholar
• Liu Z, Sun Y, Zhen H, Nie C. Network pharmacology integrated with transcriptomics deciphered the potential mechanism of codonopsis pilosula against hepatocellular carcinoma. Evid Based Complement Alternat Med. 2022;2022:1340194. doi:10.1155/2022/1340194
   PubMed Web of Science ®Google Scholar